Guided Therapeutics (GTHP) FCF Margin (QoQ) (2011 - 2025)
Guided Therapeutics (GTHP) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41,234.00 |
| Sep 30, 2025 | -31,722.00 |
| Mar 31, 2024 | -61,667.00 |
| Jun 30, 2023 | 127,273.00 |
| Sep 30, 2022 | -1.30 Mn |
| Jun 30, 2022 | -346,000.00 |
| Mar 31, 2022 | -407,333.00 |
| Dec 31, 2021 | 398,702.00 |
| Sep 30, 2021 | 3.10 Mn |
| Dec 31, 2020 | -55,906.00 |
| Dec 31, 2019 | 2.15 Mn |
| Sep 30, 2019 | -400,000.00 |
| Jun 30, 2019 | -1.78 Mn |
| Mar 31, 2019 | -29,286.00 |
| Dec 31, 2018 | 2.43 Mn |
| Sep 30, 2018 | -2.24 Mn |
| Jun 30, 2018 | 703,750.00 |
| Mar 31, 2018 | -903,037.00 |
| Dec 31, 2017 | -90,750.00 |
| Sep 30, 2017 | 13,845.00 |